NICM
CLB icon

Neo Ivy Capital Management’s Core Laboratories CLB Stock Holding History

Neo Ivy Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12
Closed – – 486
2021
Q2 		$0 Buy
+12
New +$430 ﹤0.01% 473
2020
Q1 		– Sell
-6,869
Closed -$259K – 460
2019
Q4 		$259K Buy
+6,869
New +$309K 0.3% 152
2019
Q1 		– Sell
-7,174
Closed -$428K – 296
2018
Q4 		$428K Buy
+7,174
New +$619K 0.34% 134

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Neo Ivy Capital Management's CLB Position: Q3 2021 in Review

Neo Ivy Capital Management sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 12 shares.

Neo Ivy Capital Management first reported a position in CLB in Q4 2018 and held it in 3 quarters. The position peaked at $428K in Q4 2018. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Neo Ivy Capital Management reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Neo Ivy Capital Management sold 12 Core Laboratories shares in Q3 2021.
  • Neo Ivy Capital Management first reported a position in Core Laboratories in Q4 2018 and held it in 3 quarters.
  • Neo Ivy Capital Management's Core Laboratories position peaked at $428K in Q4 2018.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Neo Ivy Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.